David Walcott: Blood Supply as Essential Healthcare Infrastructure
David Walcott, Co-Managing Partner at Novamed Ventures, shared World Health Organization‘s post on LinkedIn:
“Blood systems are increasingly being understood not just as a hospital resource, but as critical national infrastructure that underpins modern healthcare.
Awareness efforts from the World Health Organization highlight the essential role that blood and plasma donations play across a wide range of medical conditions – from childbirth complications and trauma to cancer treatment, bleeding disorders, immune deficiencies, and chronic diseases.
What’s striking is how many aspects of healthcare depend on a reliable blood supply.
Unlike many medical products, blood cannot be manufactured at scale, making voluntary donation one of the few healthcare resources that depends directly on community participation.
That’s why health systems increasingly focus on strengthening blood collection, testing, storage, and distribution networks.
Safe and timely access to blood products is a prerequisite for effective emergency care, surgery, maternal health services, oncology treatment, and many other essential health interventions.
The implication is that resilient healthcare systems require more than hospitals, medicines, and healthcare workers – they also require sustainable donation ecosystems capable of meeting ongoing demand.
If blood donation rates remain strong and blood services continue to improve, millions of patients worldwide will have access to life-saving treatments that would otherwise be unavailable, demonstrating how individual acts of contribution can create profound public health impact.”
World Health Organization shared a post on LinkedIn:
“Chronic blood conditions.
Childbirth complications.
Cancer treatment.
Bleeding disorders.
Immune deficiencies.
Safe blood and plasma donations provide a critical lifeline for patients facing these and many other life-threatening conditions.
Everyone everywhere should have timely access to safe blood and blood products.”
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 10:49Shefina S: From Presenting to Hosting at TRANSCON 2026
-
Sep 25, 2026, 10:37Michelle Leona Cecil: Hemophilia Advocacy and the Power of Community
-
Sep 25, 2026, 10:13Michael Baria: Platelet Concentration and PRP Outcomes in Partial Rotator Cuff Tears
-
Sep 25, 2026, 09:49Haley Coleman: Volunteering to Support Hemophilia Awareness
-
Sep 25, 2026, 08:55Hitarth Mehta: BHMS Students Gain Practical Exposure to Haemophilia Diagnosis
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event